Suction type pharmaceutical composition for treating Alzheimer's disease and preparation method thereof

一种阿兹海默症、吸入式的技术，应用在药物组合、治疗用的雾化器、吸入器等方向，达到增加药物吸收疗效的效果

Inactive Publication Date: 2015-09-30
林信涌
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In addition, these drugs will cause some side effects to patients, such as nausea, headache, diarrhea, insomnia, pain, hallucinations or dizziness, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Suction type pharmaceutical composition for treating Alzheimer's disease and preparation method thereof
  • Suction type pharmaceutical composition for treating Alzheimer's disease and preparation method thereof
  • Suction type pharmaceutical composition for treating Alzheimer's disease and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0024] In order to make the advantages, spirit and characteristics of the present invention more easily and clearly understood, the following will be described and discussed in detail with reference to the accompanying drawings. It should be noted that these embodiments are only representative embodiments of the present invention, and the specific methods, devices, conditions, materials, etc. exemplified therein are not intended to limit the present invention or the corresponding embodiments.

[0025] The present invention provides an inhalation pharmaceutical composition for treating Alzheimer's disease, which comprises a first gas and an atomized medicinal liquid. The first gas contains hydrogen, and the concentration of hydrogen in gas volume of the inhalation pharmaceutical composition is between 2% and 96%. The nebulized drug solution is composed of Rivastigmine Hydrogen Tartrate, Donepezil Hydrochloride, Galantamine Hydrobromide and Memantine Hydrochloride One or a comb...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention provides a suction type pharmaceutical composition for treating Alzheimer's disease and a preparation method thereof, including a first gas and an atomization soup. The first gas includes hydrogen, the hydrogen having a gas volume concentration of 2%-96% in the suction type pharmaceutical composition. The atomization soup includes one of the groups selected from rivastigmine hydrogen tartrate, donepezil hydrochloride, galanthamine hydrobromide and memantine hydrochloride or a composition thereof. The suction type pharmaceutical composition removes malignant free radical in a patient via the hydrogen, increases pharmaceutical absorption effect of the patient via the atomization soup, and indirectly reduces side effect of the drug to a human body due to usage of little atomization soup dosage.

Description

technical field [0001] The invention relates to an inhalation pharmaceutical composition and a preparation method thereof, in particular to an inhalation pharmaceutical composition for treating Alzheimer's disease and a preparation method thereof. Background technique [0002] Alzheimer's disease (Alzheimer's disease, AD) is mainly a symptom of cognitive decline. People with Alzheimer's disease will gradually lose memory and have language and emotional barriers. Therefore, a lot of social costs will be spent on the treatment of the disease and the daily care of the patient, and the life of the patient's family will be greatly affected at the same time. [0003] Therefore, the treatment of Alzheimer's disease has become a very important issue. Currently, there are two types of drugs approved by the US Food and Drug Administration (FDA) for the treatment of Alzheimer's disease. One is the receptor Antagonist (N-Methyl-D-Aspartate, NMDA) representative drug is memantine hydroc...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/55A61K9/72A61P25/28
CPCA61K9/0073A61M11/005A61M15/0085A61M16/12A61M16/14C25B1/04A61M2205/8231C25B15/08A61K31/46A61K31/48A61K31/5386A61K31/137A61K31/198A61K31/277A61P25/28Y02E60/36C25B9/17A61K31/27A61K31/445A61K47/02A61K31/13A61K31/55A61K9/0004A61K9/007A61K31/165A61K31/192A61K31/197A61K31/21A61K31/34A61K31/405A61K31/4152A61K31/4365A61K31/439A61K31/4406A61K31/4422A61K31/498A61K31/519A61K31/554A61K31/616A61K31/635
Inventor 林信涌
Owner 林信涌
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap